Advisortrust Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Advisortrust Partners's AZN Position: Q3 2026 in Review
Advisortrust Partners increased its AstraZeneca (AZN) stake by 18% in Q3 2026, buying an estimated $833K and bringing the position to 33,282 shares worth $5.37M. The position accounts for 1.69% of the portfolio, ranked #16.
Advisortrust Partners first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Advisortrust Partners held 33,282 shares of AstraZeneca worth $5.37M as of Q3 2026.
- Advisortrust Partners bought 4,998 AstraZeneca shares in Q3 2026, an estimated $833K.
- AstraZeneca made up 1.69% of Advisortrust Partners's portfolio in Q3 2026, its #16 holding.
- Advisortrust Partners first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Advisortrust Partners's 13F filing for Q3 2026, filed 2 Nov 2026.